期刊文献+

多西环素对离体大鼠心肌缺血再灌注后缝隙连接分布及心律失常的影响 被引量:2

Effects of doxycycline on the distribution of gap junction and susceptibility of arrhythmias in isolated ischemia-reperfusion rat hearts
下载PDF
导出
摘要 目的研究多西环素对离体大鼠心肌缺血再灌注后心律失常易感性的影响,并通过分析缝隙连接的重新分布探讨其可能机制。方法 48只大鼠随机分为空白对照组、缺血再灌组、多西环素干预组。采用Langendorff灌注系统,制备离体大鼠缺血再灌注模型,用ELISA方法检测各组间大鼠心肌基质金属蛋白酶-9(MMP-9)的含量,通过Western-blot方法及免疫荧光标记方法检测心肌Cx43的分布及含量。用电生理方法观察多西环素对缺血再灌注后室性快速性心律失常发生的影响。结果缺血再灌组及多西环素干预组较空白对照组MMP-9水平显著增高(P<0.001)。多西环素干预组较缺血再灌组MMP-9水平显著降低(P<0.001)。多西环素干预组再灌注后自发性室速的发生率有所减低、室性快速性心律失常诱发率显著降低(P<0.05)。多西环素能够显著减轻缺血再灌注引起的Cx43侧化分布,但Cx43的数量没有显著改变(P>0.05)。结论多西环素可通过减少MMP-9的表达,减轻缺血后缝隙连接的侧化分布并减少再灌注心律失常发生。 Aim To investigate the effects and the possible mechanisms of doxycycline on the susceptibility of ventricular tachyarrhythmias in isolated ischemia-reperfusion rat hearts.Methods 48 isolated rat hearts perfused with a langendorff instrument were divided into blank group,ischemia-reperfusion group and doxycycline intervention group(n=16,respectively).Matrix metalloproteinase-9(MMP-9)were detected by ELISA.Cx43 in the cardiomyocytes were quantified by western-blotting and localized by immunofluorescence.The risk of inducible ventricular tachyarrhythmias was evaluated by electrophysiological study.Results Doxycycline could significantly dilute MMP-9 in the ischemia-reperfusion rat hearts(P〈0.001).Ventricular tachyarrhythmias tended to be reduced in doxycycline-perfused hearts(P〈0.05).Redistribution of Cx43 can be observed in the tissue of doxycycline-perfused hearts.Conclusion Doxycycline can prevent gap junction redistribution by reducing MMP-9 in the heart tissue,thereby decrease inducible ventricular tachyarrhythmias in ischemia-reperfusion hearts.
出处 《安徽医药》 CAS 2011年第8期941-944,共4页 Anhui Medical and Pharmaceutical Journal
基金 安徽省自然科学基金资助项目(No11040606M156)
关键词 多西环素 缝隙连接 缺血再灌注损伤 离体心脏 室性快速性心律失常 doxycycline gap junction ischemia-reperfusion injury isolated heart ventricular tachyarrhythmias
  • 相关文献

参考文献4

二级参考文献76

  • 1张俊峰,葛恒,郭炳诗,邵琴,王长谦.细胞外基质金属蛋白酶诱导因子在巨噬和泡沫细胞中的表达[J].上海交通大学学报(医学版),2006,26(3):225-228. 被引量:10
  • 2Gary Rosenberg.Matrix metalloproteinases and their multiple roles in neurodege-nerative diseases[J].Lancet Neurol,2009,8(2):205-16.
  • 3Rath T,Roderfeld M,Graf J,et al.Matrix metalloproteinases in inflammatory bowel disease-from basic research to clinical significance[J].ZGastroenterol,2009,47(8):758-69.
  • 4Gillian M,Hideaki N.Progress in matrix metalloproteinase research[J].Molecular Aspects of Medicine,2008,29(5):290–308.
  • 5Joseph DRaffetto,Raouf A,Khalil.Matrix Metalloproteinases and their Inhibitors in Vascular Remodeling and Vascular Disease[J].Biochem Pharmacol,2008,75(2):346-59.
  • 6Al-Dasooqi N,Gibson RJ,Bowen JM,et al.Matrix metalloproteinases.key regulators in the pathogenesis of chemotherapy-induced mucositis?[J].Cancer Chemother Pharmacol,2009,64(1):1-9.
  • 7Creemers EEJM,Cleutjens JPM,Smits JFM,et al.Matrix metalloproteinase inhibition after myocardial infarction.:a new approach to prevent heart failure[J].Circ Res,2001,89(3):201-10.
  • 8Lacour AG,Gervaix A,Zamora SA,et al.Procalcitonin,IL-6,IL-8,IL-l receptor antagonist and C-reactive protein as identificaters of serious bacterial infections in children with fever withou localising signs[J].Eur J Pediatr,2001,160(2):95-100.
  • 9Brian D,Lamon,David P,et al.Inflammation at the Molecular Interface of Atherogenesis[J].The American Journal of Pathology,2008,173(5):1253-64.
  • 10Javier Mestas,Klaus Ley.Monocyte-Endothelial Cell Interactions in the Develo-pmentn of Atherosclerosis[J].Trends Cardiovasc Med,2008,18(6):228-32.

共引文献23

同被引文献14

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部